The potential role of prebiopsy magnetic resonance imaging combined with prostate-specific antigen density in the detection of prostate cancer

International Journal of Urology

Volumn 15, Issue 4, 2008, Pages 322-326

  Kubota, Yasuaki ^a,b   Kamei, Shingo ^a   Nakano, Masahiro ^a   Ehara, Hidetoshi ^a   Deguchi, Takashi ^a   Tanaka, Osamu ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b GIFU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Magnetic resonance imaging; Prostate cancer; PSA density

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; SENSITIVITY AND SPECIFICITY; TRANSRECTAL ULTRASONOGRAPHY;

EID: 41749100598     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2008.01991.x     Document Type: Article

References (20)

1. Benson MC, Whang IS, Pantuck A et al. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J. Urol. 1992 147:815 16.
2. Kalish J, Cooner WH, Graham SD Jr. Serum PSA adjusted for Volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland Volume (PSAD) in detecting adenocarcinoma of the prostate. Urology 1994 43:601 6.
3. Brawer MK, Aramburu EA, Chen GL, Preston SD, Ellis WJ. The inability of prostate specific antigen index to enhance the predictive value of prostate specific antigen in the diagnosis of prostatic carcinoma. J. Urol. 1993 150:369 73.
4. Catalona WJ, Richie JP, deKernion JB et al. Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves. J. Urol. 1994 152:2031 6.
5. Ikonen S, Karkkainen P, Kivisaari L et al. Magnetic resonance imaging of clinically localized prostatic cancer. J. Urol. 1998 159:915 19.
6. Gjengsto P, Paus E, Halvorsen OJ et al. Predictors of prostate cancer evaluated by receiver operating characteristics partial area index: prospective institutional study. J. Urol. 2005 173:425 8.
7. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983 148:839 43.
8. Villeirs GM, Verstraete KL, De Neve WJ, De Meerleer GO. Magnetic resonance imaging anatomy of the prostate and periprostatic area: a guide for radiotherapists. Radiother. Oncol. 2005 76:99 106.
9. Ikonen S, Kivisaari L, Vehmas T et al. Optimal timing of post-biopsy MR imaging of the prostate. Acta. Radiol. 2001 42:70 3.
10. Wefer AE, Hricak H, Vigneron DB et al. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J. Urol. 2000 164:400 4.
11. Rahmouni A, Yang A, Tempany CM et al. Accuracy of in-vivo assessment of prostatic Volume by MRI and transrectal ultrasonography. J. Comput. Assist. Tomogr. 1992 16:935 40.
12. Lin DW, Gold MH, Ransom S, Ellis WJ, Brawer MK. Transition zone prostate specific antigen density: lack of use in prediction of prostatic carcinoma. J. Urol. 1998 160:77 82.
13. Ikonen S, Karkkainen P, Kivisaari L et al. Magnetic resonance imaging of prostatic cancer: does detection vary between high and low gleason score tumors? Prostate 2000 43:43 8.
14. Zlotta AR, Djavan B, Marberger M, Schulman CC. Prostate specific antigen density of the transition zone: a new effective parameter for prostate cancer prediction. J. Urol. 1997 157:1315 21.
15. Gohji K, Nomi M, Egawa S et al. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations. Cancer 1997 79:1969 76.
16. Matsumoto K, Satou T, Egawa S et al. Efficacy and morbidity of transrectal ultrasound-guided 12-core biopsy for detection of prostate cancer in Japanese men. Int. J. Urol. 2005 12:353 60.
17. Takenaka A, Hara R, Hyodo Y et al. Transperineal extended biopsy improves the clinically significant prostate cancer detection rate: a comparative study of 6 and 12 biopsy cores. Int. J. Urol. 2006 13:10 14.
18. Introini C, Naselli A, Vigliercio G, Spina B, Truini M, Puppo P. Can biopsy be a reliable predictor of spatial distribution of prostate cancer? Comparison of a novel biopsy regimen with radical prostatectomy findings. Urology 2006 68:1301 4.
19. Futterer JJ, Engelbrecht MR, Huisman HJ et al. Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers. Radiology 2005 237:541 9.
20. Kirkham AP, Emberton M, Allen C. How good is MRI at detecting and characterizing cancer within the prostate? Eur. Urol. 2006 50:1163 75.